NCT04550767 is a clinical trial in Bacterial Infection, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT04550767?

NCT04550767 is sponsored by University Hospital, Montpellier.

What condition does NCT04550767 study?

NCT04550767 studies Bacterial Infection.

Is NCT04550767 still recruiting?

NCT04550767 is currently completed. Last updated 18 September 2020.

Last reviewed 2020-09-18 · How we verify

NCT04550767

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

: Bacterial Infections in Injecting Drug Users

Completed Last updated 18 September 2020

What this trial tests

trial in Bacterial Infection in 117 participants. Completed in 1 January 2019.

Timeline

17 January 2012

Primary endpoint
1 December 2018

1 January 2019

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Completed
Study type	OBSERVATIONAL
Enrollment	117
Start date	17 January 2012
Primary completion	1 December 2018
Estimated completion	1 January 2019
Sites	1 location across France

Conditions studied

Bacterial Infection — all drugs for Bacterial Infection →

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Bacterial Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bacterial infections in people who inject psychoactive substances

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bacterial Infection

Currently open trials in the same condition.

NCT07285785 — Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea · Phase 4 · recruiting
NCT06709521 — Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI) · Phase 4 · recruiting

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04550767 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 18 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04550767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing